GB0710781D0 - Methods of assessing and treating multiple-organ failure - Google Patents
Methods of assessing and treating multiple-organ failureInfo
- Publication number
- GB0710781D0 GB0710781D0 GB0710781A GB0710781A GB0710781D0 GB 0710781 D0 GB0710781 D0 GB 0710781D0 GB 0710781 A GB0710781 A GB 0710781A GB 0710781 A GB0710781 A GB 0710781A GB 0710781 D0 GB0710781 D0 GB 0710781D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- assessing
- methods
- organ failure
- treating multiple
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0710781A GB0710781D0 (en) | 2007-06-06 | 2007-06-06 | Methods of assessing and treating multiple-organ failure |
PCT/GB2008/001943 WO2008149103A1 (en) | 2007-06-06 | 2008-06-06 | Methods of assessing and treating multiple-organ failure |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0710781A GB0710781D0 (en) | 2007-06-06 | 2007-06-06 | Methods of assessing and treating multiple-organ failure |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0710781D0 true GB0710781D0 (en) | 2007-07-18 |
Family
ID=38318760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0710781A Ceased GB0710781D0 (en) | 2007-06-06 | 2007-06-06 | Methods of assessing and treating multiple-organ failure |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0710781D0 (en) |
WO (1) | WO2008149103A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2891412A1 (en) | 2012-11-20 | 2014-05-30 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase |
RU2536278C1 (en) * | 2013-11-25 | 2014-12-20 | Анна Сергеевна Семенова | Method for prediction of early complications following coronary artery bypass graft surgery |
RU2536279C1 (en) * | 2013-11-25 | 2014-12-20 | Анна Сергеевна Семенова | Method for prediction of complications following coronary artery bypass graft surgery |
US20230043689A1 (en) * | 2021-03-03 | 2023-02-09 | Qatar University | Biomarkers for predicting intensive care unit stay duration for mechanically ventilated covid-19 patients |
CN113995854B (en) * | 2021-11-09 | 2023-04-14 | 中山大学 | Glutathione-sensitive nano drug delivery system and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005053947A1 (en) * | 2005-11-11 | 2007-05-16 | Univ Ernst Moritz Arndt | New medicines |
-
2007
- 2007-06-06 GB GB0710781A patent/GB0710781D0/en not_active Ceased
-
2008
- 2008-06-06 WO PCT/GB2008/001943 patent/WO2008149103A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008149103A1 (en) | 2008-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190214T1 (en) | Compositions and methods for treating purpura | |
IL208518A0 (en) | Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions | |
EP2097012A4 (en) | Devices and methods for the treatment of heart failure | |
IL194975A0 (en) | Composition and methods for treatment of congestive heart failure | |
IL207360A0 (en) | Methods of diagnosing and treating parp - mediated diseases | |
IL202015A0 (en) | Methods and compositions for treating skin conditions | |
HK1147254A1 (en) | 5-anilinoimidazopyridines and methods of use 5- | |
EP2200977A4 (en) | F1f0-atpase inhibitors and related methods | |
EP2249854A4 (en) | Improved treatment and prophylaxis | |
HK1162366A1 (en) | Devices and methods for treating and or preventing diseases | |
IL209895A (en) | Compounds for preventing and/or treating ß -amyloidoses | |
EP2170311A4 (en) | Compounds and methods for treating or preventing autoimmune diseases | |
IL197781A0 (en) | Lyophilization methods and apparatuses | |
IL206125A0 (en) | Azaindolizines and methods of use | |
HK1245679A1 (en) | Methods and compositions for treating dermatological diseases and conditions | |
EP2171086A4 (en) | Methods of diagnosing and treating cancer | |
IL204728A0 (en) | Methods and compounds for treating retinol-related diseases | |
IL211459A0 (en) | Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders | |
EP2049899A4 (en) | Methods to prevent and treat diseases | |
GB0710781D0 (en) | Methods of assessing and treating multiple-organ failure | |
PL2368357T3 (en) | Improved maintaining of security and integrity | |
EP2155239A4 (en) | Methods for decreasing immune response and treating immune conditions | |
ZA200902533B (en) | Methods for treating and reducing the incidence of Newcastle disease | |
IL207428A0 (en) | Agents for treating and/or avoiding fire blight | |
GB0714500D0 (en) | composition and treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |